Logo tutelle Logo tutelle
Logo tutelle Logo tutelle


Sur ce site

Sur le Web du CNRS

Accueil du site > Équipes > Équipe 1 RNA, RNP : Structure-Fonction-Maturation

Publications hospitalières


  • Hettal L, Stefani A, Salleron J, Courrech F, Behm-Ansmant I, Constans JM, Gauchotte G, Vogin G.  Radiomics Method for the Differential Diagnosis of Radionecrosis Versus Progression after Fractionated Stereotactic Body Radiotherapy for Brain Oligometastasis.  Radiat Res. 2020 Mar 11. doi: 10.1667/RR15517.1.
    PMID: 32160109


  • Vogin G, Wambersie A, Koto M, Ohno T, Uhl M, Fossati P, Balosso J; ULICE WP2 working group. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the
    facilities in operation based on a case of skull base chordoma. Radiat Oncol. 2019 Feb 1;14(1):24. doi: 10.1186/s13014-019-1224-1. 2018 Q2 IF 2.895
    PMID: 30709366
  • Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemartin C, Lherm Y, Villeneuve L, Kepenekian V, Marchal F; RENAPE Network. Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry. Ann Surg Oncol. 2019 Mar;26(3):852-860. doi: 10.1245/s10434-018-07153-2. 13. 2018 Q2 IF 3.681
    PMID: 30635798


  • Vogin G, Wambersie A, Pötter R, Beuve M, Combs SE, Magrin G, Mayer R, Mock U, Sarrut D, Schreiner T, Fossati P, Balosso J. Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce. Cancer Radiother. 2018 Dec;22(8):802-809. doi: 10.1016/j.canrad.2017.11.016.  2018 Q4 IF 1.263
    PMID: 30327228
  • Vogin G, Merlin JL, Rousseau A, Peiffert D, Harlé A, Husson M, Hajj LE, Levitchi M, Simon T, Simon JM. Absence of correlation between radiation-induced CD8 T-lymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation. Oncotarget. 2018 Aug 24;9(66):32680-32689. doi: 10.18632/oncotarget.26001. eCollection 2018 Aug 24.
    PMID: 30220974
  • Peiffert D, Baumann AS, Serre AA, Vendrely V, Rouard N, Faivre JC, Vogin G. [Anal canal cancer: In the era of intensity-modulated radiotherapy, outstanding issues]. Cancer Radiother. 2018 Oct;22(6-7):509-514. doi: 10.1016/j.canrad.2018.07.131. Epub 2018 Sep 1. Review. French. 2018 Q4 IF 1.263
    PMID: 30181029
  • Thariat J, Tessonnier T, Bonvalot S, Lerouge D, Mammar H, Bolle S, Claren A, Duffaud F, Alapetite C, Vogin G. [Proton therapy in soft tissue and bone sarcomas]. Bull Cancer. 2018 Sep;105(9):830-838. doi: 10.1016/j.bulcan.2018.05.008. Review. French. 2018 Q1 IF 0.729
    PMID: 30126610
  • Vogin G, Fleckenstein J, Servotte JC, Nickers P, Ebersberger A, Mohammad F, Bragard I, Coucke P, Untereiner M, Peiffert D, Braun M  NHL-ChirEx: An interprofessional cross-border education initiative in the Greater Region with a focus on radiation morbidity and patient safety. Radiother Oncol. 2018 Jul 10. pii: S0167-8140(18)33346-2. doi: 10.1016/j.radonc.2018.06.031. 2018 Q1 IF 5.262
  • Bernier-Chastagner V, Hettal L, Gillon V, Fernandes L, Huin-Schohn C, Vazel M, Tosti P, Salleron J, François A, Cérimèle E, Perreira S, Peiffert D, Chastagner P, Vogin G  Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE). BMC Cancer. 2018 Jul 6;18(1):719. doi: 10.1186/s12885-018-4652-7. 2018 Q3 IF 2.933
  • Vogin G, Bastogne T, Bodgi L, Gillet-Daubin J, Canet A, Pereira S, Foray N The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):690-693. doi: 10.1016/j.ijrobp.2018.03.047. 2018 Q1 IF 6.203
  • Sargos P, Charleux T, Haas RL, Michot A, Llacer C, Moureau-Zabotto L, Vogin G, Le Péchoux C, Verry C, Ducassou A, Delannes M, Mervoyer A, Wiazzane N, Thariat J, Sunyach MP, Benchalal M, Laredo JD, Kind M, Gillon P, Kantor G. Pre- and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation oncologists. Cancer Radiother. 2018 Apr;22(2):131-139. doi: 10.1016/j.canrad.2017.09.004. 2018 Q4 IF 1.263
  • Pereira S, Bodgi L, Duclos M, Canet A, Ferlazzo ML, Devic C, Granzotto A, Deneuve S, Vogin G, Foray N. Fast and Binary Assay for Predicting Radiosensitivity Based on the Theory of ATM Nucleo-Shuttling: Development, Validation, and Performance. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):353-360. doi: 10.1016/j.ijrobp.2017.10.029. 2018 Q1 IF 6.203


  • Nesseler JP, Salleron J, Rios M, Nickers P, Marchal F, Brocard F, Peiffert D, Vogin G. A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.  Radiother Oncol. 2017 Oct;125(1):160-167. doi: 10.1016/j.radonc.2017.08.037. PMID:28951009
  • Goupy F, Chajon E, Castelli J, Le Prisé É, Duvergé L, Jaksic N, Vogin G, Monpetit É, Klein V, de Bosschère L, Maingon P. [Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum]. Cancer Radiother. 2017 Oct;21(6-7):613-618. doi: 10.1016/j.canrad.2017.07.036. PMID:28886980
  • Royer P, Salleron J, Vogin G, Taillandier L, Clément-Duchêne C, Klein O, Faivre JC, Peiffert D, Bernier V. [Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?] Cancer Radiother. 2017 Dec;21(8):731-740. doi: 10.1016/j.canrad.2017.02.005. PMID:28711413
  • Nesseler JP, Peiffert D, Vogin G, Nickers P. [Cancer, radiotherapy and immune system]. Cancer Radiother. 2017 Jun;21(4):307-315. doi: 10.1016/j.canrad.2017.02.002. PMID: 28501459
  • Gamelon-Bénichou C, Oldrini S, Charra-Brunaud C, Vogin G, Salleron J, Peiffert D.  [Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique]. Cancer Radiother. 2017 May;21(3):171-179. doi: 10.1016/j.canrad.2016.11.007. PMID: 28457817
  • Oldrini G, Huertas A, Renard-Oldrini S, Taste-George H, Vogin G, Laurent V, Salleron J, Henrot P. Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One. 2017 Apr 25;12(4):e0176118. doi: 10.1371/journal.pone.0176118. PMID: 28441447


  • Faivre JC, Py JF, Vogin G, Martinage G, Salleron J, Royer P, Grandgirard N, Pasquier D, Thureau S  [Conformal radiotherapy for vertebral bone metastasis]. Cancer Radiother. 2016 Oct;20(6-7):493-9. doi: 10.1016/j.canrad.2016.07.081. PMID: 27614498 
  • Oldrini G, Leroux A, Vogin G, Rios M, Marchal F, Sirveaux F, Verhaeghe JL, Renard-Oldrini S, Lesanne G, Salleron J, Henrot P.  Comparison of the histopathological results of the radioguided percutaneous microbiopsies and the operative specimens of soft tissue tumors of limbs, trunk and retroperitoneum. Presse Med. 2016 Nov;45(11):e363-e368. doi: 10.1016/j.lpm.2016.01.036. PMID: 27597301 
  • Vogin G, Golfier F, Hajri T, Leroux A, Weber B.  A HELLP syndrome complicates a gestational trophoblastic neoplasia in a perimenopausal woman: a case report. BMC Cancer. 2016 Aug 2;16:573. doi: 10.1186/s12885-016-2641-2. PMID: 27485461 
  • Jumeau R, Renard-Oldrini S, Courrech F, Buchheit I, Oldrini G, Vogin G, Peiffert D.  High dose rate brachytherapy with customized applicators for malignant facial skin lesions. Cancer Radiother. 2016 Jul;20(5):341-6. doi: 10.1016/j.canrad.2016.03.008. PMID: 27321412 
  • Fourquet J, Sunyach MP, Vilotte F, Le Péchoux C, Ranchère-Vince D, Bonvalot S, Coindre JM, Terrier P, Meeus P, Helfre S, Martin E, Vogin G, Biau J, Kao W, Noel G, Ducassou A, Llacer-Moscardo C, Stoeckle E, Penel N, Sargos P.  Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group. Radiother Oncol. 2016 Jul;120(1):156-62. doi: 10.1016/j.radonc.2016.04.037. PMID: 27207359 
  • Le Rhun E, Dhermain F, Vogin G, Reyns N, Metellus P. Radionecrosis after stereotactic radiotherapy for brain metastases. Expert Rev Neurother. 2016 Aug;16(8):903-14. doi: 10.1080/14737175.2016.1184572.  PMID: 27177183 
  • COPERNIC project investigators, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, Rouvet I, Zabot MT, Joubert A, Vincent A, Dalla Venezia N, Bourguignon M, Canat EP, d'Hombres A, Thébaud E, Orbach D, Stoppa-Lyonnet D, Radji A, Doré E, Pointreau Y, Bourgier C, Leblond P, Defachelles AS, Lervat C, Guey S, Feuvret L, Gilsoul F, Berger C, Moncharmont C, de Laroche G, Moreau-Claeys MV, Chavaudra N, Combemale P, Biston MC, Malet C, Martel-Lafay I, Laude C, Hau-Desbat NH, Ziouéche A, Tanguy R, Sunyach MP, Racadot S, Pommier P, Claude L, Baleydier F, Fleury B, de Crevoisier R, Simon JM, Verrelle P, Peiffert D, Belkacemi Y, Bourhis J, Lartigau E, Carrie C, De Vathaire F, Eschwege F, Puisieux A, Lagrange JL, Balosso J, Foray N. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60. doi: 10.1016/j.ijrobp.2015.11.013.  PMID: 26867874 
  • Vogin G, Calugaru V, Bolle S, George B, Oldrini G, Habrand JL, Mammar H, Dendale R, Salleron J, Noël G, Feuvret L.  Investigation of ectopic recurrent skull base and cervical chordomas: The Institut Curie's proton therapy center experience. Head Neck. 2016 Apr;38 Suppl 1:E1238-46. doi: 10.1002/hed.24199.  PMID: 26339866